Neuroendocrine Tumor Research Foundation

NETRF is the global leader of neuroendocrine cancer research driving innovation across 71 institutions in 16 countries to advance our understanding and treatment of this complex, formidable disease. We are committed to making an impact today while investing in a future free from neuroendocrine cancer. Our hybrid approach funds leading-edge research and provides essential resources and support to patients and their families, empowering them with the tools and knowledge to navigate their diagnosis and treatment. Since 2005, we have funded $37.6 million in research projects. The Neuroendocrine Research Foundation is a 501(c)(3) organization, so all donations are fully tax-deductible to the extent allowed by law. We are grateful to you for your generosity.